United Kingdom · Question · Written question
HL HL15394
Thyroid Diseases: Medical Treatments
Introduced
10 March 2026
Last action
23 March 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 March 2026
Summary
To ask His Majesty's Government what steps they are taking to address regional disparities in thyroid treatment, particularly variations in prescribing liothyronine between different integrated care boards.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 March 2026
Written question
To ask His Majesty's Government what steps they are taking to address regional disparities in thyroid treatment, particularly variations in prescribing liothyronine between different integrated care boards.
Source: Lords
23 March 2026
Answer
Integrated care boards (ICBs) are responsible for supporting appropriate prescribing in their areas, taking account of this guidance and individual clinical circumstances.National Health Service regions cascaded the Items which should not be routinely pre...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-03-10/HL15394
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1889877
- uk · wq-1889877 · source updated 23 March 2026